Literature DB >> 12712005

Optimizing outcomes with maximal surgical resection of malignant gliomas.

Stephen J Hentschel1, Raymond Sawaya.   

Abstract

BACKGROUND: Aggressive surgical resection of malignant gliomas is a controversial issue in neurosurgery. Studies with rigorous methodology that fully address this issue have only recently become available.
METHODS: The controversy regarding the role of maximal surgical resection of malignant gliomas is reviewed. The authors discuss surgical techniques and adjunctive technologies that can be utilized to assist in resection of these lesions.
RESULTS: Using current microneurosurgical techniques, it is possible to resect malignant gliomas in gross total fashion. An aggressive approach in which 98% or more of the tumor mass is resected results in a statistically significant survival advantage.
CONCLUSIONS: An aggressive surgical procedure for malignant gliomas can result in increased survival duration for selected groups of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12712005     DOI: 10.1177/107327480301000202

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  25 in total

1.  Cytotoxic T-cells as imaging probes for detecting glioma.

Authors:  Ali Syed Arbab
Journal:  World J Clin Oncol       Date:  2010-11-10

2.  Neurosurgical robotic system for brain tumor removal.

Authors:  Jumpei Arata; Yasunori Tada; Hiroaki Kozuka; Tomohiro Wada; Yoshitaka Saito; Norio Ikedo; Yuichiro Hayashi; Masazumi Fujii; Yasukazu Kajita; Masaaki Mizuno; Toshihiko Wakabayashi; Jun Yoshida; Hideo Fujimoto
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-07-13       Impact factor: 2.924

3.  Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study.

Authors:  Thibault Smets; Tévi Morel Lawson; Cécile Grandin; Aleksandar Jankovski; Christian Raftopoulos
Journal:  Eur Radiol       Date:  2013-01-12       Impact factor: 5.315

4.  Intraoperative DTI and brain mapping for surgery of neoplasm of the motor cortex and the corticospinal tract: our protocol and series in BrainSUITE.

Authors:  Giancarlo D'Andrea; Albina Angelini; Andrea Romano; Antonio Di Lauro; Giovanni Sessa; Alessandro Bozzao; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2012-02-28       Impact factor: 3.042

5.  Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging.

Authors:  C R McDonald; N S White; N Farid; G Lai; J M Kuperman; H Bartsch; D J Hagler; S Kesari; B S Carter; C C Chen; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

6.  Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas.

Authors:  Mohammed A M Osman
Journal:  Ann Transl Med       Date:  2014-05

7.  Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas.

Authors:  Meryem Aktan; Mehmet Koc; Gul Kanyilmaz
Journal:  Ann Transl Med       Date:  2015-11

8.  Effects of perfusion on diffusion changes in human brain tumors.

Authors:  Alexander D Cohen; Peter S LaViolette; Melissa Prah; Jennifer Connelly; Mark G Malkin; Scott D Rand; Wade M Mueller; Kathleen M Schmainda
Journal:  J Magn Reson Imaging       Date:  2013-02-06       Impact factor: 4.813

9.  Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.

Authors:  Ali S Arbab; Branislava Janic; Kourosh Jafari-Khouzani; A S M Iskander; Sanath Kumar; Nadimpalli R S Varma; Robert A Knight; Hamid Soltanian-Zadeh; Stephen L Brown; Joseph A Frank
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

10.  Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience.

Authors:  Alan T Villavicencio; Sigita Burneikiene; Pantaleo Romanelli; Laura Fariselli; Lee McNeely; John D Lipani; Steven D Chang; E Lee Nelson; Melinda McIntyre; Giovanni Broggi; John R Adler
Journal:  Neurosurg Rev       Date:  2009-07-25       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.